Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

“BioGend” Interbody Fusion System 001 Cage

K-Number: K233075 · 2024-03-06

Decision Date2024-03-06
Product CodeMAX
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

“BioGend” Interbody Fusion System 001 Cage is a medical device manufactured by Biogend Therapeutics Co., Ltd.. It received FDA 510(k) clearance on 2024-03-06 under approval number K233075. The device is classified under product code MAX. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the “BioGend” Interbody Fusion System 001 Cage?

“BioGend” Interbody Fusion System 001 Cage is a medical device that received FDA 510(k) clearance on 2024-03-06. It is manufactured by Biogend Therapeutics Co., Ltd.. The 510(k) number is K233075.

When was “BioGend” Interbody Fusion System 001 Cage approved by the FDA?

“BioGend” Interbody Fusion System 001 Cage received FDA 510(k) clearance on 2024-03-06, under approval number K233075.

What company makes “BioGend” Interbody Fusion System 001 Cage?

“BioGend” Interbody Fusion System 001 Cage is manufactured by Biogend Therapeutics Co., Ltd..

What is the FDA product code for “BioGend” Interbody Fusion System 001 Cage?

The FDA product code for “BioGend” Interbody Fusion System 001 Cage is MAX.

Related Clinical Trials

Related PubMed Literature

Related Devices (Code: MAX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.